INSPIRE BIOTHERAPEUTICS

Inspire Biotherapeutics Inc. ("Inspire"), an emerging biotech company with a mission to create life-saving gene therapies for monogenic and acquired diseases of the lung, is poised to move its novel lung tropic AAV gene therapy into clinical validation... Inspire's Business Founders - C3i Center Inc, Octane Medical Group of Companies, and Ontario Institute for Regenerative Medicine - are providing investment, corporate development, and commercialization strategy... Inspire's mission is to create life-saving gene therapies for individuals with devastating diseases of the lung. Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. Inspire is currently pursuing initiation of a First-in-Human clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to..

Also known as: Inspire Biotherapeutics Inc.